(S (NP (EX There)) (VP (VBZ has) (VP (VBN been) (NP (NP (JJ remarkable) (NN progress)) (PP (IN in) (S (VP (VBG identifying) (NP (NP (DT the) (NN perplexity)) (PP (IN of) (NP (NP (JJ genomic) (NN landscape)) (PP (IN of) (NP (NN cancer)))))) (PP (IN over) (NP (DT the) (JJ past) (CD two) (NNS decades))) (, ,) (S (VP (VBG providing) (NP (PRP us)) (NP (DT a) (ADJP (NN brand) (JJ new)) (NN way)) (S (VP (TO to) (VP (VB understand) (NP (NP (NN cancer)) (CC and) (NP (JJ anti-cancer) (NNS drugs)))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (S (NP (PRP it)) (VP (VBZ is) (ADJP (ADJP (RB extremely) (JJ expensive)) (CC and) (ADJP (NN time) (HYPH -) (VBG consuming))) (S (VP (TO to) (VP (VB develop) (NP (JJ anti-cancer) (NNS drugs))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN diversity)) (PP (IN of) (NP (NML (NML (NN cancer) (JJ genomic) (NNS features)) (CC and) (NML (NN drug))) (JJ molecular) (NNS features)))) (VP (VBZ renders) (S (NP (PRP it)) (ADJP (RB considerably) (JJ difficult) (S (VP (TO to) (VP (VB customize) (NP (NN therapy) (NN strategy)) (PP (IN for) (NP (NNS patients)))))))))) (. .))
(S (PP (IN In) (NP (NN order) (S (VP (TO to) (VP (VB facilitate) (NP (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (JJ new) (JJ anti-cancer) (NNS drugs)))) (CC and) (NP (NP (DT the) (NN selection)) (PP (IN of) (NP (NNS drugs))))) (S (VP (TO to) (VP (VB provide) (NP (JJ personalized) (NN treatment) (NN strategy)))))))))) (, ,) (NP (PRP we)) (VP (VBP seek) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (JJ different) (JJ anti-cancer) (NNS drugs)))) (PP (IN with) (NP (NML (JJ deep) (NN learning)) (NNS models))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP test) (NP (PRP$ our) (NN model)) (PP (IN on) (NP (NML (NN breast) (NN cancer)) (NN cell) (NNS lines))) (PP (IN at) (ADVP (RB first)))) (, ,) (CC and) (ADVP (RB then)) (VP (VB generalize) (NP (PRP$ our) (NN method)) (PP (IN on) (NP (NN pan-cancer) (NN dataset))))) (. .))
(S (NP (PRP We)) (VP (VBP incorporate) (NP (NP (CD 2) (NNS kinds)) (PP (IN of) (NP (NP (JJ essential) (NN information)) (PP (IN for) (NP (JJ anti-cancer) (NN drug) (NN response) (NN prediction)))))) (PP (IN into) (NP (NP (PRP$ our) (NN model)) (, ,) (NP (ADVP (RB namely)) (NP (NN gene) (NN expression) (NNS data)) (PP (IN of) (NP (NML (NN cancer) (NN cell)) (NNS lines)))) (CC and) (NP (NN drug) (JJ molecular) (NNS data))))) (. .))
(S (PP (IN In) (NP (NN order) (S (VP (TO to) (VP (VB extract) (NP (NN representative) (NNS features)) (PP (IN from) (NP (DT these) (JJ unlabeled) (NNS data)))))))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (JJ variational) (NN autoencoder) (-LRB- -LRB-) (NN VAE) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN proved) (S (VP (TO to) (VP (VB be) (ADJP (RB very) (JJ powerful) (PP (IN in) (NP (JJ unsupervised) (NN learning)))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP reach) (NP (NP (DT an) (JJ average) (NN coefficient)) (PP (IN of) (NP (NP (NN determination) (PRN (-LRB- -LRB-) (FRAG (NP ($ $)) (NP (NP (NN R)) (SYM ^) (NP (-LRB- {) (CD 2) (-RRB- })))) (FRAG (NP (SYM =) (CD 0.83)) (NP ($ $)))) (-RRB- -RRB-)) (PP (IN in) (S (VP (VBG predicting) (NP (NP (NP (NN drug) (NN response)) (PP (IN on) (NP (NML (NN breast) (NN cancer)) (NN cell) (NNS lines)))) (CC and) (NP (NP (DT an) (JJ average) (NN $) (NN R)) (SYM ^) (NP (-LRB- {) (CD 2) (-RRB- }))) (NML (NML (QP (SYM >) (CD 0.84))) (NML ($ $)))) (PP (IN on) (NP (NML (NN pan-cancer) (NN cell)) (NNS lines)))))))))) (. .))
(S (S (NP (PRP We)) (ADVP (RB further)) (VP (VB explore) (S (NP (DT the) (NN latent) (NNS representations)) (VP (VBN encoded) (PP (IN by) (NP (NML (NNP geneVAE) (CC and) (NNP JTVAE)) (NN model))))))) (, ,) (CC and) (S (NP (DT the) (NNS results)) (VP (VBP show) (SBAR (S (NP (DT these) (NNS models)) (VP (VP (VBP are) (ADJP (JJ robust))) (CC and) (VP (MD can) (VP (VB preserve) (NP (NP (JJ critical) (NNS features)) (PP (IN of) (NP (JJ original) (NNS data))))))))))) (. .))
